Ruth L. Sacks

Ruth L. Sacks

Oncology

1365 Clifton Road Northeast
BldgC
Atlanta, GA 30322

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

SACI-IO HR+: a randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.

SACI-IO HR+: a randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: March 20, 2026

SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.

SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: March 20, 2026

Is more always better? Low-dose pembrolizumab as a practical step toward more equitable triple-negative breast cancer care.

Is more always better? Low-dose pembrolizumab as a practical step toward more equitable triple-negative breast cancer care.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: January 29, 2026

Quality Improvement Intervention to Improve Head and Neck Cancer Care in Safety Net Hospital Settings: Outcomes From a Single-Visit Multidisciplinary Clinic Model.

Quality Improvement Intervention to Improve Head and Neck Cancer Care in Safety Net Hospital Settings: Outcomes From a Single-Visit Multidisciplinary Clinic Model.

Journal: Head & neck

Published: December 11, 2025

Top advances of the year: Breast cancer.

Top advances of the year: Breast cancer.

Journal: Cancer

Published: December 10, 2024

Antibody-Drug Conjugates in Triple Negative Breast Cancer.

Antibody-Drug Conjugates in Triple Negative Breast Cancer.

Journal: Clinical breast cancer

Published: May 17, 2023

Trop-2 as a Therapeutic Target in Breast Cancer.

Trop-2 as a Therapeutic Target in Breast Cancer.

Journal: Cancers

Published: November 03, 2022

When the World Throws You a Curve Ball: Lessons Learned in Breast Cancer Management.

When the World Throws You a Curve Ball: Lessons Learned in Breast Cancer Management.

Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

Published: May 06, 2021

Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study.

Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study.

Journal: ESMO open

Published: November 17, 2020

Outcomes of patients with oropharyngeal squamous cell carcinoma treated with induction chemotherapy followed by concurrent chemoradiation compared with those treated with concurrent chemoradiation.

Outcomes of patients with oropharyngeal squamous cell carcinoma treated with induction chemotherapy followed by concurrent chemoradiation compared with those treated with concurrent chemoradiation.

Journal: Cancer

Published: August 24, 2020

Subjective functional outcomes in oropharyngeal cancer treated with induction chemotherapy using the MD Anderson Symptom Inventory (MDASI).

Subjective functional outcomes in oropharyngeal cancer treated with induction chemotherapy using the MD Anderson Symptom Inventory (MDASI).

Journal: Laryngoscope investigative otolaryngology

Published: August 13, 2020

Unique Patterns of Distant Metastases in HPV-Positive Head and Neck Cancer.

Unique Patterns of Distant Metastases in HPV-Positive Head and Neck Cancer.

Journal: Oncology

Published: October 24, 2019

Showing 1-12 of 12

Last Updated: 09/26/2026